Perspective on the Budgetary Impact of FP/FORM pMDI on Treatment and Management of Exacerbation in Moderate-to-Severe Asthma Patients in Singapore.

Sebastien BoisseauMurtaza QasuriWeng Tong HoWrik GhoshYacine Hadjiat

Published in: ClinicoEconomics and outcomes research : CEOR (2020)

The analysis provides a perspective that the increased access to FP/FORM could help achieve drug and exacerbation cost savings for the treatment of moderate-to-severe asthma.

Keyphrases

chronic obstructive pulmonary disease
end stage renal disease
ejection fraction
chronic kidney disease
high intensity
intensive care unit
patient reported outcomes
replacement therapy
electronic health record